Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Drug Safety
|
July 3, 2002
Renal failure associated with the use of celecoxib and rofecoxib
Syed R Ahmad, Cindy Kortepeter, Allen Brinker, et al.
JACC. Heart Failure
|
August 4, 2018
Reply: Catecholamine-Mediated Pathways in Takotsubo Syndrome: Does it Matter If it Is a Serotonin Norepinephrine Reuptake Inhibitor or a Selective Serotonin Reuptake Inhibitor?
Daniel Woronow, Courtney Suggs, Robert Levin, et al.
JAMA Internal Medicine
|
August 29, 2022
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
Daniel Woronow, Christine Chamberlain, Ali Niak, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Labeling and Drug Safety Communication Approaches to Loperamide Abuse
Daniel Woronow, Kimberley A Swank, Eileen Wu, et al.
JACC. Heart Failure
|
March 31, 2018
Takotsubo Common Pathways and SNRI Medications
Daniel Woronow, Courtney Suggs, Robert L Levin, et al.
Journal of the American Pharmacists Association : Japha
|
January 12, 2017
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse
Kimberley A Swank, Eileen Wu, Cindy Kortepeter, et al.
Annals of Internal Medicine
|
May 7, 2019
Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases
Susan J Bersoff-Matcha, Christine Chamberlain, Christian Cao, et al.
The American Journal of Psychiatry
|
May 3, 2002
Clozapine and venous thromboembolism
Cindy Kortepeter, Min Chen, James F Knudsen, et al.
Journal of Clinical Psychopharmacology
|
April 30, 2022
Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents
Mohamed Mohamoud, Qi Chen, David Croteau, et al.
Clinical Pharmacology and Therapeutics
|
April 6, 2023
Assessment of the Impact of Mandated Postmarketing Pediatric-Focused Safety Reviews on Safety-Related Regulatory Actions 2013-2019
Mohamed Mohamoud, Carmen Cheng, Debra Ryan, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Drug Safety
|
July 3, 2002
Renal failure associated with the use of celecoxib and rofecoxib
Syed R Ahmad, Cindy Kortepeter, Allen Brinker, et al.
JACC. Heart Failure
|
August 4, 2018
Reply: Catecholamine-Mediated Pathways in Takotsubo Syndrome: Does it Matter If it Is a Serotonin Norepinephrine Reuptake Inhibitor or a Selective Serotonin Reuptake Inhibitor?
Daniel Woronow, Courtney Suggs, Robert Levin, et al.
JAMA Internal Medicine
|
August 29, 2022
Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration
Daniel Woronow, Christine Chamberlain, Ali Niak, et al.
JACC. Clinical Electrophysiology
|
May 16, 2018
Labeling and Drug Safety Communication Approaches to Loperamide Abuse
Daniel Woronow, Kimberley A Swank, Eileen Wu, et al.
JACC. Heart Failure
|
March 31, 2018
Takotsubo Common Pathways and SNRI Medications
Daniel Woronow, Courtney Suggs, Robert L Levin, et al.
Journal of the American Pharmacists Association : Japha
|
January 12, 2017
Adverse event detection using the FDA post-marketing drug safety surveillance system: Cardiotoxicity associated with loperamide abuse and misuse
Kimberley A Swank, Eileen Wu, Cindy Kortepeter, et al.
Annals of Internal Medicine
|
May 7, 2019
Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases
Susan J Bersoff-Matcha, Christine Chamberlain, Christian Cao, et al.
The American Journal of Psychiatry
|
May 3, 2002
Clozapine and venous thromboembolism
Cindy Kortepeter, Min Chen, James F Knudsen, et al.
Journal of Clinical Psychopharmacology
|
April 30, 2022
Acute Hyperkinetic Movement Disorders as a Multifactorial Pharmacodynamic Drug Interaction Between Methylphenidate and Risperidone in Children and Adolescents
Mohamed Mohamoud, Qi Chen, David Croteau, et al.
Clinical Pharmacology and Therapeutics
|
April 6, 2023
Assessment of the Impact of Mandated Postmarketing Pediatric-Focused Safety Reviews on Safety-Related Regulatory Actions 2013-2019
Mohamed Mohamoud, Carmen Cheng, Debra Ryan, et al.
Page
of 3